HLA System Autoimmunity and Genomics | Decoding Inflammation

By Alberto Rivera, MD · 2026-05-21 · 6 min read

The Most Polymorphic Region in the Human Genome

The human leukocyte antigen (HLA) system, encoded in a dense 4-megabase region of chromosome 6, is the most polymorphically complex region in the human genome. More than 30,000 HLA alleles have been characterized across the class I (HLA-A, B, C) and class II (HLA-DR, DQ, DP) loci. This extraordinary diversity reflects the immune system's evolutionary imperative: the broader the range of peptide fragments an individual's HLA molecules can present, the broader the spectrum of pathogens the adaptive immune system can recognize and target.

The same diversity that enables broad pathogen recognition creates a liability: HLA molecules that bind self-peptides with inappropriate affinity can trigger autoreactive T cell activation, the founding event of most autoimmune diseases.

HLA Alleles and Disease Risk: The Associations Are Mechanistic

HLA-DQ2 and HLA-DQ8 are carried by greater than 95 percent of celiac disease patients. These variants bind gliadin-derived peptides with high affinity, presenting them to CD4+ T cells in a context that drives the pro-inflammatory Th1 response that destroys intestinal villi. HLA-DR4 is associated with rheumatoid arthritis, carrying risk alleles in the shared epitope region of the DRB1 gene that preferentially present citrullinated peptides to autoreactive T cells.

HLA-B27 is carried by 90 percent of ankylosing spondylitis patients and misfoldsirresistibly in the endoplasmic reticulum, triggering an unfolded protein response that activates NF-κB and the IL-23/IL-17 inflammatory axis in entheseal tissue. The allele itself is the inflammatory mechanism, not a marker for it.

The Broader Inflammatory Architecture

HLA-mediated autoimmune risk does not operate in genomic isolation. TNF-α promoter variants within the HLA region compound inflammatory signaling. Deficits in regulatory T cell function, determined by IL-2 pathway variants and FOXP3 polymorphisms, determine whether the peripheral immune tolerance mechanisms that check autoreactive cells can compensate for the HLA-mediated presentation risk.

The GENEFLAMMATION framework maps HLA class II alleles alongside the broader inflammatory regulatory architecture to identify patients at high autoimmune risk and design preventive immune modulation strategies, before the clinical autoimmune diagnosis crystallizes from a genomic predisposition that was always present.